Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro

Augusto, Everton Faccini; Rosa, Maria Luiza Garcia; Cavalcanti, Sílvia M. B.; Oliveira, Ledy H. S.

doi:10.1007/s00404-012-2511-3

Cited by 24 publications

(28 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Distrust of health care professionals as a result of previous negative experiences were also found (24,25). These barriers are primarily related to lower education and lower socio-economic status (15,26).…”

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 92%

“…Physical or mental disability (27), sexual abuse (28), belonging to groups of immigrants (26) or rural living (16) are barriers to screening based on predominantly psychological causes. These include fear of the examinations, shame, harm, and psychological blocks, and they occur due to lack of knowledge and a low awareness of the danger of cervical cancer and its prevention (23).…”

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 99%

“…Lower participation in cervical cancer screening programs was also found in groups of women with lower education, and these barriers are described as educational barriers to cervical cancer screening (30,31). However, low cervical cancer screening participation of women with lower education is not a rule (26).…”

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 99%

“…Behavioral and cultural barriers to cervical cancer screening include feelings that they would be neglecting family responsibilities and child care at the time of visiting the doctor (15,25) or the fear of the examination and feelings of shame (36). Women in some cultural groups were discouraged from screening if the doctor was male and they were prejudiced to such examinations (26). Forgetting the term of screening appointments was also considered to be one of the behavioral barriers (36).…”

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 99%

See 3 more Smart Citations

Selected Risk Factors for Cervical Cancer and Barriers to Cervical Cancer Screening

Szabóová

Svlhrova

Hudeckova

2014

Acta Medica Martiniana

View full text Add to dashboard Cite

A b s t r a c tThe article provides a review of literature on risk factors and cofactors for cervical cancer and barriers to cervical cancer screening. Cofactors of cervical cancer are risk factors that contribute to the development of cervical cancer but are not able to generate cancer on their own. Risk factors and cofactors of cervical cancer have been clearly identified in many studies. Therefore cervical cancer is a preventable type of cancer. The aim of this article was to describe in more detail the barriers to cervical cancer screening among women all over the world. The barriers to cervical cancer screening can be sorted according to the results of studies into five main groups: informational, psychological, socio-economic, behavioral and cultural, and geographical. Efforts to reduce risk factors and cofactors of HPV infection and cervical cancer and to increase knowledge about screening are necessary in a positive approach to preventing cervical cancer in society and to promote women's health.

show abstract

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 92%

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 99%

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 99%

Section: A C T a M E D I C A M A R T I N I A N A 2 0 1 4 14/2mentioning

confidence: 99%

See 2 more Smart Citations

Selected Risk Factors for Cervical Cancer and Barriers to Cervical Cancer Screening

Szabóová

Svlhrova

Hudeckova

2014

Acta Medica Martiniana

View full text Add to dashboard Cite

show abstract

“…A Dutch survey of nonattendees of cervical cancer screening programs found they associated feelings of anxiety, shame and insecurity with screening [54]. Fear of pain and embarrassment were identified as barriers to cervical cancer screening in a recently published survey study from Brazil [55]. A specific potential harm was illustrated by a study reporting higher rates of urinary tract infection in the 7 weeks after a routine pelvic examination with cervical cancer screening [56].…”

mentioning

confidence: 99%

Should the Annual Pelvic Examination Go the Way of Annual Cervical Cytology?

MacLaughlin

Faubion

Long

et al. 2014

Womens Health (Lond Engl)

View full text Add to dashboard Cite

sey theThe value of pelvic examination for healthy asymptomatic women has been called into question given the lack of benefit for ovarian and endometrial cancer screening, the ability to screen for sexually transmitted infections without a pelvic examination, and the uncoupling of the procurement of contraception with a pelvic examination. Still, there are indications for performing pelvic examinations in symptomatic women and in some high risk women. How do we as clinicians apply current evidence and expert opinion to our medical practice? Our recommendation to consider a pelvic examination at 3−5-year intervals with cervical cancer screening to elicit gynecologic and sexual health concerns offers a compromise between continuation of unnecessary annual pelvic examinations and complete elimination of these examinations. Keywords: bimanual • pelvic examination • screening • speculum examination BackgroundPelvic examination indications for healthy asymptomatic women have encompassed such preventive services as screening for cancer and infection. They have been associated with contraception counseling, evaluation and initiation. In previous years, pelvic examinations were performed annually for women in conjunction with cervical cancer screening, regardless of medical history or symptoms. In the past decade, cervical cancer screening guidelines have changed significantly favoring less frequent screening for most women. The most recent national guideline updates from the USA recommend cervical cytology every 3 years for women aged 21 years and older and include the option of 5-year cervical cytology/high-risk HPV co-testing for women 30-65 years old [1][2][3]. This has resulted in a major change in healthcare visit frequency. Women no longer need to schedule annual appointments for cervical cancer screening. Healthcare providers and researchers appropriately question the value of the annual pelvic examination for healthy asymptomatic women, its relationship to other gynecologic and preventive healthcare, and seek guidance regarding counseling patients. Herein, we will review traditional indications for pelvic examinations and review evidence and best practices from the USA and around the world. We will provide our perspective on answering the question: 'Should the annual pelvic examination go the way of annual cervical cytology?' What does a pelvic examination include?A comprehensive pelvic examination entails more than cervical cancer screening. It generally includes visualization of the external genitalia, a speculum examination of the vaginal and cervix, a bimanual examination of the uterus and adnexal areas, and a rectovaginal examination. The examination may include collection of cervical cytology (with or without HPV testing) for cervical cancer screening and endocervical or vaginal specimens to evaluate for infection. Pelvic examinations have commonly been performed for screening, symptom assessment and surveillance [4].Should the annual pelvic examination go the way of annual cervical cytology? Kathy Pelv...

show abstract

Factors Influencing Clinical Follow‐Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing

Chadwell

Knapke³

et al. 2018

Journal of Genetic Counseling

View full text Add to dashboard Cite

Genetic testing for inherited cancer risk has recently improved through the advent of multi-gene panels and the addition of deletion and duplication analysis of the BRCA genes. The primary aim of this study was to determine which factors influence the intent of individuals with a personal history of breast and/or ovarian cancer and negative or uncertain BRCA1 and BRCA2 testing to return to a hereditary cancer program for additional genetic risk assessment, counseling, and testing. Surveys were sent to 1197 individuals and 257 were returned. Of those participants who were planning to return to clinic, most cited having family members who could benefit from the test result as the primary motivation to return. Many participants who were not planning to return to clinic cited the cost of testing as a barrier to return. Cost of testing and concerns about insurance coverage were the most commonly cited barriers for the group of participants who were undecided about returning to clinic. Results from this study may be used to guide re-contact efforts by clinicians to increase patient uptake to return to clinic for up-to-date genetic risk assessment, counseling, and testing.

show abstract

Barriers to cervical cancer screening in women attending the Family Medical Program in Niterói, Rio de Janeiro

Cited by 24 publications

References 16 publications

Selected Risk Factors for Cervical Cancer and Barriers to Cervical Cancer Screening

Selected Risk Factors for Cervical Cancer and Barriers to Cervical Cancer Screening

Should the Annual Pelvic Examination Go the Way of Annual Cervical Cytology?

Factors Influencing Clinical Follow‐Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing

Contact Info

Product

Resources

About